CLINICAL_TRIALS
trial_result
· 2024-12-10
Clinical Trial Update: Galcanezumab for Vestibular Migraine [Phase 2]
Summary
A Phase 2 trial evaluating galcanezumab for vestibular migraine has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of California, San Francisco | Conditions: Vestibular Migraine | Phase 2 | Status: COMPLETED | Results posted: 2024-12-10